YH12852, a Potent and Selective Receptor Agonist of 5‐hydroxytryptamine, Increased Gastrointestinal Motility in Healthy Volunteers and Patients With Functional Constipation

Gastrointestinal (GI) motility disorders are common, decreases quality of life, and imposes a substantial economic burden. YH12852 is a novel agonist of 5‐hydroxytryptamine for the treatment of GI motility disorders. This phase I/IIa study assessed the tolerability, pharmacodynamic (PD) and pharmaco...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Hyun A., Ju Moon, Seol, Yoo, Hyounggyoon, Kyung Kim, Mi, Bok Jang, Seong, Lee, Seoungoh, Kim, Sohee, Lee, Howard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993265/
https://www.ncbi.nlm.nih.gov/pubmed/33202093
http://dx.doi.org/10.1111/cts.12924

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993265/
https://www.ncbi.nlm.nih.gov/pubmed/33202093
http://dx.doi.org/10.1111/cts.12924

Ejemplares similares